PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Effect of COVID-19 pandemic on mortality in people with intellectual disabilities extended beyond deaths from COVID itself

Mortality from COVID-19 in people with intellectual disabilities five times higher than general population

2023-04-17
(Press-News.org) Mortality from COVID-19 in people with intellectual disabilities five times higher than general population Study showed death rates for cancers, mental health disorders, circulatory disorders, external causes, and other natural causes in people with intellectual disabilities were higher during the COVID pandemic than pre-pandemic Observed effects likely to be due a range of factors including disruptions to care during pandemic PLEASE NOTE Embargo: 0030H CEST Copenhagen time Monday 17 April 

*Note: this is a joint press release from the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) and The Lancet Public Health.  Please credit both the congress and the journal in your stories*

New research presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (Copenhagen, 15-18 April) and published in The Lancet Public Health shows that the impact of COVID-19 on mortality in people living with intellectual disabilities extended beyond deaths from the virus itself, and was linked with increased mortality in several other conditions. The study is by Dr Maarten Cuypers, Radboud University Medical Center, Nijmegen, the Netherlands, and colleagues.

Although high rates of COVID-19-related deaths have been reported for people with intellectual

disabilities during the first 2 years of the pandemic, it is unknown to what extent the pandemic has impacted existing mortality disparities for people with intellectual disabilities.

This population-based cohort study used a pre-existing cohort that included the entire Dutch adult population (everyone aged ≥18 years) on Jan 1, 2015, and identified people with presumed intellectual disabilities through data linkage. For all individuals within the cohort who died up to and including Dec 31, 2021, mortality data were obtained from the Dutch mortality register.

Therefore, for each individual in the cohort, information was available about demographics (sex and date of birth), indicators of intellectual disability, if any, based on chronic care and (social) services use, and in case of death, the date and underlying cause of death. The authors compared the first 2 years of the COVID-19 pandemic (2020 and 2021) with the pre-pandemic period (2015–19). The primary outcomes in this study were all-cause and cause-specific mortality. They calculated rates of death and generated hazard ratios (HRs) using statistical modelling.

At the start of follow-up in 2015, 187 149 Dutch adults with indicators of intellectual disability were enrolled and 12.6 million adults from the general population were included. Mortality from COVID-19 was five times higher in the population with intellectual disabilities than in the general population, with a particularly large disparity at younger ages (22 times higher below 30 years of age, and still nine times higher below 60 years of age) that declined with increasing age.

The overall mortality from all causes disparity during the COVID-19 pandemic (HR 3.38 times higher) was 5% higher (than before the pandemic (3.23 times higher), This increased overall mortality disparity was not completely explained by the excess risk for people with intellectual disabilities to die from COVID-19, but increasing mortality disparities were also seen for causes related to cancer, mental, behavioural and nervous system disorders, and external causes.  Thus, although people with intellectual disabilities were already facing a pre-existing mortality disparity, the magnitude of this risk difference relative to the general population increased during the pandemic.

The authors say: “Our study showed that the full impact of the COVID-19 pandemic has been much greater than indicated by reported deaths due to COVID-19 alone. Existing mortality disparities between people with and without intellectual disabilities have been further widened compared with the period 2015–19.”

They conclude: “The health risks for people with intellectual disabilities warrant targeted policy making regarding protective measures for the current pandemic and future pandemic preparedness that go beyond the causative agent of a pandemic alone. This study shows the need for better monitoring of vulnerable populations, such as people with disabilities, who are at risk of otherwise being overlooked, with marked consequences.”

Dr Maarten Cuypers, Radboud Institute for Health Sciences,Radboud University Medical Center, Nijmegen, the Netherlands. T) +31 24 36 18181 E) maarten.cuypers@radboudumc.nl

Alternative contact Tony Kirby in the ECCMID Media Centre. T) +44 7834 385827 E) tony@tonykirby.com

The Lancet Public Health: All-cause and cause-specific mortality among people with and without intellectual disabilities during the COVID-19 pandemic in the Netherlands: a population-based cohort study

To be presented at a special Lancet journals COVID-19 session in Hall I of the European Congress on Clinical Microbiology & Infectious Diseases (ECCMID 2023) in Copenhagen on Monday April 217 at 16.15-18.15 Copenhagen time (CEST).

 

END


ELSE PRESS RELEASES FROM THIS DATE:

Connections in the brain involved in epileptic seizures identified

2023-04-17
Researchers at the UCL Queen Square Institute of Neurology have discovered a network of connections in the brain linked to seizures in people with epilepsy. The team believe that their findings, published in Brain, will help redesign neurological operations for patients whose epilepsy can’t be controlled by medication. By disconnecting certain pathways in the frontal lobe, patients may be able to enjoy long-lasting freedom from seizures. There are 500,000 people in the UK with epilepsy and 50 million people have the condition worldwide. But one in three cannot ...

New details of Tully monster revealed

New details of Tully monster revealed
2023-04-17
For more than half a century, the Tully monster (Tullimonstrum gregarium), an enigmatic animal that lived about 300 million years ago, has confounded paleontologists, with its strange anatomy making it difficult to classify. Recently, a group of researchers proposed a hypothesis that Tullimonstrum was a vertebrate similar to cyclostomes (jawless fish like lamprey and hagfish). If it was, then the Tully monster would potentially fill a gap in the evolutionary history of early vertebrates. Studies ...

Environmental toxin PCB found in deep sea trench

Environmental toxin PCB found in deep sea trench
2023-04-17
PCB has been banned in most countries since the 1970s, but that doesn't mean it no longer exists. Now, deep-sea researchers report that they have found PCB at the bottom of the Atacama Trench in the Pacific Ocean. During their expedition to the deep-sea trench, the research team retrieved sediment cores and analyzed them for PCB occurrences at five different locations in the trench. All the samples of surface sediment analyzed contained PCB. The study, led by Professor Anna Sobek from the Department of Environmental Science at Stockholm University and Professor Ronnie N. Glud, director of the Danish Center for Hadal Research at ...

KERI accredited as an inspection body by ACCREDIA for electrical equipment

KERI accredited as an inspection body by ACCREDIA for electrical equipment
2023-04-17
The Korea Electrotechnology Research Institute (KERI, President Kim Nam-Kyun), an internationally accredited testing and certification body for electrical equipment, has been accredited as a Type A Inspection Body by ACCREDIA, an international accreditation body in Italy. An Inspection Body verifies the performance and quality of products, and an Accreditation Body attests and supervises Inspection Bodies to ensure their competence and impartiality. ACCREDIA is a world leader in accreditation for electrical equipment. It is a full member of the International Accreditation ...

NCCS research luminaries conferred distinguished professorships in pathology and colorectal surgery

2023-04-17
Singapore, 16 April 2023 – The SingHealth Duke-NUS Academic Medical Centre (AMC) announced that Distinguished Professorships have been awarded to two research luminaries from the National Cancer Centre Singapore (NCCS). The Professorships are the highest honour bestowed upon faculty members by the SingHealth Duke-NUS AMC. Professor Teh Bin Tean, Deputy Chief Executive Officer (Research), NCCS, and Professor, Duke-NUS Medical School, was conferred the Tan Yew Oo Professorship in Pathology and Associate Professor Iain Tan Bee Huat, Division Director of Research and Senior Consultant, Division of Medical Oncology, ...

Lower risk of severe illness and death in newborns of low-income immigrant than Canadian-born females

2023-04-17
Newborns of non-refugee immigrant females are at overall lower risk of serious illness and death than those of Canadian-born females in low-income neighbourhoods in Ontario, according to new research published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.221711. Previous research has looked at the risk of adverse outcomes for newborns in low- v. high-income neighbourhoods, but there is little evidence on the respective risks for immigrant and nonimmigrant mothers living in similar low-income neighbourhoods. Both immigration status and living in a low-income ...

Income rank linked to experience of physical pain, irrespective of whether in a rich or poor country, study suggests

2023-04-17
A new study of worldwide polling data suggests that a person’s income rank relative to their peers is linked to their experience of physical pain, with a lower income rank linked to a higher likelihood of experiencing pain. It is the first time such a relationship has been shown. The study found the link to persist, to the same degree, irrespective of whether the person lives in a rich country or a poor country. Income rank is the position of an individual’s absolute personal income amount in a list of those amounts ordered from lowest to highest.  The higher the position in the list, the higher the income ...

Treatment with immunotherapy alone produces ‘exceptional’ response rates in some melanoma patients

2023-04-16
COLUMBUS, Ohio ­– Data from a national clinical trial shows that a striking 89% of patients with desmoplastic melanoma responded to immunotherapy (pembrolizumab) alone, suggesting that many patients could avoid the risk for toxicity from combination therapies and achieve cancer control with this approach to treatment. Desmoplastic melanoma is a subset of melanoma skin cancer that is caused by high levels of ultraviolet (UV) radiation damage and, therefore, a high number of tumor mutations that all contribute to aggressive ...

SWOG S1512 trial sees high response rate to pembrolizumab in patients with unresectable desmoplastic melanoma

2023-04-16
Close to 90 percent of patients with unresectable (inoperable) desmoplastic melanoma, a rare form of skin cancer, saw their cancer improve after treatment with the immunotherapy drug pembrolizumab in a recent clinical trial. These results from the S1512 trial conducted by the SWOG Cancer Research Network, a group funded by the National Cancer Institute (NCI), are being delivered in an oral presentation at the clinical trials plenary session of the 2023 annual meeting of the American Association for Cancer Research (AACR) in Orlando, Florida, on April 16th. The S1512 ...

AACR: YAP/TEAD inhibitor VT3989 is well tolerated and shows antitumor activity in advanced mesothelioma and NF2-mutant cancers

AACR: YAP/TEAD inhibitor VT3989 is well tolerated and shows antitumor activity in advanced mesothelioma and NF2-mutant cancers
2023-04-16
ABSTRACT: CT006 ORLANDO, Fla. ― The first-in-class YAP/TEAD inhibitor VT3989 was well tolerated with durable antitumor responses in patients with advanced malignant mesothelioma and other tumors with NF2 mutations, according to results of a Phase I trial led by researchers at The University of Texas MD Anderson Cancer Center. The first-in-human study was presented today at the American Association for Cancer Research (AACR) Annual Meeting 2023. Seven of 69 patients had radiological partial responses that persisted up to at least 21 months, indicating tumor shrinkage, while 34 had stable disease. Patient benefit was observed in patients with both mesothelioma ...

LAST 30 PRESS RELEASES:

Making lighter work of calculating fluid and heat flow

Normalizing blood sugar can halve heart attack risk

Lowering blood sugar cuts heart attack risk in people with prediabetes

Study links genetic variants to risk of blinding eye disease in premature infants

Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain

AI can pick up cultural values by mimicking how kids learn

China’s ecological redlines offer fast track to 30 x 30 global conservation goal

Invisible indoor threats: emerging household contaminants and their growing risks to human health

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

[Press-News.org] Effect of COVID-19 pandemic on mortality in people with intellectual disabilities extended beyond deaths from COVID itself
Mortality from COVID-19 in people with intellectual disabilities five times higher than general population